Utility of a novel point-of-care test in detecting coronary artery disease following negative nuclear testing: a case series.

Mustafa Alkhawam¹, Timothy Burton², Horace R Gillins³, Cody Harris⁴, Shyam Ramchandani², Charles R Bridges³, Parminder B Singh⁵, Tracy Neal⁴

¹Division of Cardiovascular Disease, The University of Alabama at Birmingham, 1720 2nd Ave South Birmingham, AL 35294, USA.

²Analytics for Life, 100 King St W Suite 5600, Toronto, ON M5X 1C9, Canada.

³CorVista Health, 3 Bethesda Metro Center, Suite 700, Bethesda, MD 20814, USA.

⁴Cullman Regional Medical Group, 1912 Alabama Highway 157, Ground Floor, Main Hospital, Cullman, AL 35058, USA.

⁵Marion General Hospital, 1000 McKinley Park Dr, Marion, OH 43302, USA.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Coronary artery disease (CAD) often presents diagnostic challenges, especially in patients with atypical chest pain that persists despite negative non-invasive testing. For instance, nuclear stress testing, although widely used, may yield false-negative results, particularly in cases of balanced ischaemia. Accurate diagnostics are essential to avoid delays in diagnosis and treatment, p…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.